Seattle, Wash., Durham, N.C., and Pittsburgh, Pa., USA
Objective:
We explored the association between cognitive function and risk of Parkinson's disease (PD). Background: Cognitive deficits have been documented in patients with PD but whether decreased cognitive function precedes PD diagnosis is unknown. Methods: The Cardiovascular Health Study enrolled 5,888 adults aged 65 years and older in the US. Cognitive function was measured at baseline using the digit symbol substitution test (DSST) and the 100-point modified mini-mental state (3MS) examination. Higher scores indicate better function in both tests. We identified PD from 1989 through 2007 using self-report, medications, inpatient ICD-9 codes, medical charts, and Medicare information including outpatient services, skilled nursing homes, hospice, home healthcare, and type of physician submitting the claim. Two movement disorders specialists adjudicated final PD status. We assessed the association between performance on DSST and 3MS and PD risk using multivariate Cox regression models. Results: We identified 165 incident cases of PD over 70,796 person-years of follow-up. After adjusting for age, gender, race, education, smoking, alcohol consumption, depression and diabetes, higher DSST score was associated with a decreased risk of PD (HR = 0.97; 95% CI: 0.96, 0.99). Those in the highest DSST quartile were substantially less likely to develop PD (HR = 0.53, 95% CI: 0.30, 0.94). The HR for the highest vs. lowest quartile for 3MS was 0.73 (95% CI: 0.40, 1.30), although this association was not statistically significant. In secondary analyses that excluded incident PD within 5 years of baseline, continuous DSST score remained inversely associated with PD risk (p = 0.03). Conclusion: Deficits in processing speed and perhaps cognitive function precede PD diagnosis, but it remains unknown whether these are etiologic factors themselves, manifestations of a shared etiology, or early pre-motor indicators of PD.
O2
Cumulative Exposure to Lead and Cognition in Persons with Parkinson's Disease J. Weuve, D.Z. Press, F. Grodstein, R.O. Wright, H. Hu, M.G. Weisskopf Boston, Mass., New York, N.Y., USA and Toronto, Ont., Canada Objective: To evaluate the association between cumulative lead exposure and cognitive function in Parkinson's Disease (PD). Background: Dementia is an important consequence of Parkinson's disease (PD), with few known modifiable risk factors. Cumulative exposure to lead, at levels experienced in the community, may exacerbate PD-related neural dysfunction, resulting in impaired cognition. Methods: We evaluated cumulative lead exposure, gauged by tibia and patella bone lead concentrations, among 101 persons with PD ('cases') and, separately, 50 persons without PD ('controls'). We assessed cognitive function using a telephone battery developed and validated in a separate sample of PD patients. We used linear regression techniques to estimate the association between bone lead and cognitive function adjusted for potential confounders. We assessed the interaction between lead and case-control status by including a multiplicative interaction term between the two in the model. Results: After multivariable adjustment, higher tibia bone lead concentration among PD cases was associated with worse performance on all of the individual telephone tests. In particular, tibia lead levels corresponded to significantly worse performance on a telephone analog of the Mini-Mental State Examination and tests of working memory and attention. Moreover, higher tibia bone lead concentration was associated with significantly worse global composite score encompassing all the cognitive tests (P = 0.04). The magnitude of association per standard deviation increment in tibia bone lead level was equivalent to the difference in global scores among controls in our study, who were approximately 7 years apart in age. The tibia lead-cognition association was notably stronger within cases than within controls (P(difference) = 0.06). Patella bone lead concentration was not consistently associated with performance on the tests. Conclusions: These data provide evidence suggesting that cumulative exposure to lead may result in worsened cognition among persons with PD.
Abstracts

O3
Non-Motor Subtypes of Early Parkinson Disease in the Parkinson's Progression Markers Initiative
S. Jain, S. Young Park
Pittsburgh, Pa., USA Objective: To explore whether subtypes of Parkinson disease (PD) may be defined by non-motor features in a cohort of recently diagnosed PD patients. Background: Parkinson disease (PD) is a multi-system, multi-organ disease with varied clinical presentations and pathologic changes in the central nervous system and peripheral end-organs. The clinical period commences with a premotor phase characterized by varied non-motor features follow by motor signs that lead to diagnosis. As non-motor features predate motor signs, characterizing patterns of non-motor features in early PD my inform models of pathogenesis and disease surveillance. Methods: The Parkinson's Progression Markers Initiative is an observational cohort which currently contains 345 individuals with PD who at enrollment were: at least 30 years old; diagnosed within that last 2 years; and not treated for PD. Baseline assessments of motor, neurobehavioral, cognitive, autonomic, sleep and olfactory features were completed. K-means cluster analysis was performed using baseline non-motor characteristics. The number of clusters was determined by comparing the sum of squared error (SSE) distance between each member of a cluster and the cluster center in actual data versus 250 randomized versions. To plot clusters, principal components analyses were performed. Clusters were validated by ANOVA and Fischer's exact test on variables not used for clustering. Results: Four PD subtypes derived from nonmotor features emerged (% of PD population): (1) Cognitive and Olfactory Impairment (17%) with the most impaired cognitive and olfactory function; (2) Younger onset, mildest non-motor features, slowest progression (32%); (3) Intermediate burden (38%); and (4) Non-cognitive, non-motor impairment with rapid progression (13%) with the most severe sleep, depressive and autonomic symptoms and highest prevalence of impulsive/compulsive features. Conclusions: These preliminary results suggest PD subtypes defined by non-motor features exist early in the clinical period. Such patterns of non-motor features may be present prior to diagnostic motor signs in longitudinal cohorts with incident PD cases.
O4 Physical Trauma and Risk of ALS: A PopulationBased Study
R. Seals, J. Hansen, O. Gredal, M. Weisskopf Boston, Mass., USA, Copenhagen, and Aarhus, Denmark Objective: To assess the relationship between physical trauma and risk of ALS in Denmark. Background: Clinical observations and case-control studies have indicated that physical trauma could be a risk factor for ALS; however, many of these studies were small and relied on self-report of trauma history. We conducted the largest and most comprehensive registry-based study of trauma and ALS. Methods: Our study base is the entire population of Denmark from the years 1982 to 2009. From this population we selected all 3,650 incident ALS cases as documented in the Danish Hospital Registry, and a random sample of 100:1 age-and sex-matched controls from the Danish Central Person Registry. Trauma history from 1977 was assessed from the Danish National Hospital Registry, and each trauma was classified into one of six classes (open wounds, fractures, dislocations, nerve injuries, contusion and crushing, concussions). Prior trauma for each was considered dichotomously, both unlagged and lagged five years. Results: A history of any prior trauma was significantly associated with ALS (OR = 1.31; 95% CI 1.00-1.26). On 5 yr-lagged analysis, however, a history of any prior trauma was not associated with ALS (OR = 1.01; 95% CI 0.92-1.11). The effect of prior trauma is confined to the 365 days prior to ALS diagnosis. None of the specific traumas lagged five years showed any significant association with ALS risk, although dislocations were borderline associated (OR = 1.14; 95% CI 0.97-1.34). Conclusions: This national nested case-control study is the largest study of hospital admission for trauma and risk of subsequent ALS. Results are consistent with earlier results from smaller studies suggesting that the observed increase in ALS risk in the year following a trauma is driven by either reverse causation or over-ascertainment. There is little evidence that history of hospital-diagnosed concussion elevates ALS risk. These results apply only to trauma resulting in hospitalization.
O5
Multicenter ALS Cohort Study of Oxidative Stress and Disease Progression: Structure and Methodology H. Mitsumoto, P. Factor-Litvak, H. Andrews, R. Goetz, J. Hupf, J. Singleton, C. Campanella New York, N.Y., USA Background: ALS is a devastating, rapidly fatal neurodegenerative disease of a largely unknown cause. It is clinically characterized by progressive skeletal muscle paralysis and eventual respiratory failure. The mean survival is approximately 40 months following symptom onset, however the survival time is highly variable. No prospective investigations have attempted to determine factors which either accelerate or decelerate disease progression. Recent clinical and epidemiological studies of ALS suggest diverse environmental and lifestyle risk factors, many of which are related to the generation of oxidative stress (OS). We hypothesize that these extrinsic factors act throughout the disease course, are associated with varying levels of OS and thus influence disease progression. Methods: To test this hypothesis, we recruited 350 newly diagnosed sporadic ALS patients from 15 ALS centers across the US. Exposure to OS is measured via questionnaire and biomarkers. ALS progression is determined with the ALSFRS-R and other clinical features every 3 to 6 months up to 24 months or death. At baseline and follow-up, we obtained OS biomarkers (urinary isoprostane and 8-oxodeoxyguanosine) and lipid profiles, and we measured current and past environmental, psychological, dietary, and lifestyle factors associated with OS. Additional stored specimens include DNA, plasma and skin biopsies. Results: Statistical analyses will examine associations between OS biomarkers, lipid profiles and an empirically derived OS index based on questionnaire data and ALS progression. The OS index will include a variety of occupational, environmental, lifestyle, and psychological factors. To our knowledge, this is the first prospective, interdisciplinary, in-depth multicenter epidemiological investigation of OS related to ALS progression. Conclusion: Our project will increase the understanding of the mechanisms involved in disease prognosis and may be the first step toward new treatment to target multiple OS sites in ALS. Baseline enrollment has been completed, and we are currently following the cohort. Objective: To test the hypothesis that cotton textile workplace exposure to endotoxin is etiologically related to parkinsonism (PS) prevalence and severity in a dose-dependent manner. Background: Endotoxin (lipopolysaccharide [LPS] ) is a product of gram negative bacteria, and a widespread environmental contaminant, including in cotton dust. There is a convincing animal model of LPS-induced PS in rodents. Methods: From a previously established cohort of women textile workers in Shanghai, China, we recruited 569 retired women, aged 50-87, previously employed in cotton textile factories and an age-matched non-exposed reference group of 298 retired women textile workers from non-cotton textile factories. Approximately 97 percent of participants were never smokers. Study subjects' cumulative occupational exposure to endotoxin (endotoxin units/mg 3 x years) were available from previous research on cancer risks in this cohort. Study neurologists conducted a standardized neurological examination, including the Unified Parkinson Disease Rating Scale Motor Section (UPDRS3). Results: Based on initial exam findings, and applying a provisional case definition of UPDRS3 score >15, we identified 32 (5.6%) PS cases among exposed and 16 (5.4%) cases among non-exposed reference workers. Ongoing analysis involves identifying subjects with possible exclusionary criteria (e.g. history of stroke), refining the clinical case definition, and estimation of the exposure-response trend. These findings will be presented at the WFN meeting. Conclusion: The observed pattern of crude crosssectional results does not indicate an etiologic relation between PS and cumulative occupational endotoxin exposure in Shanghai women textile workers. However, this conclusion may change as findings from more refined analyses emerge.
O6 Environmental Predictors of Early and Late Onset Amyotrophic Lateral Sclerosis
O8 Blood Lead Concentrations in Essential TremorAn Epidemiological Study in Diyarbakir, Turkey
T. Tanrikulu, Y. Tamam, L. Tamer Gumus, O. Dogu
Diyarbakir and Mersin, Turkey
Objective: The aim of this study was to determine blood lead concentrations in patients with ET and healthy controls. Background: Two previous clinical and epidemiological studies showed increased blood lead levels in ET patients. Methods: 253 ET cases over 50 years of age ascertained from a population-based study in the province of Diyarbakır in Turkey, were matched with 261 controls from the same population. All patients and controls were examined by study neurologists. Results: Age and other de-mographic variables of the ET cases and the participants in the control group were similar. Mean (± SD) blood lead concentration for ET cases was 4.23 ± 1.7 μg/dL (range = 2.03-13.3 μg/dL), and 2.5 ± 1.1 μg/dL (range = 0.2-4.5 μg/dL) for the controls. In the unadjusted logistic regression model, blood lead concentration is correlated with diagnosis (ET case as against control): OR = 7.32; 95% CI, 4.95-10.81; p < 0.001. A correlation was found between severity of tremor (total tremor score) and blood lead concentration (r = 0.09, p < 0.03) in all sampling. The correlation between blood lead concentration and duration of tremor in ET cases was not at a significant level (r = 0.71; p = 0.23), especially after adjustment for age (r = 0.85; p = 0.37). Conclusions: These findings are similar to those of the two previous studies, and show a correlation between lead, a toxic material in the environment, and ET, a widespread neurological condition.
O9
Nodding Syndrome in W. Equatoria, South Sudan: Environmental, Nutritional and Infectious Factors P. Spencer, K. Vandemaele, M. Richer, V.S. Palmer, S. Chungong, M. Anker, Y. Ayana, M.L. Opoka Douglas, N. Klaucke, A. Quarello, J.K. Tumwine Geneva, Switzerland, Juba, South Sudan, Portland, Oreg., Brasstown, N.C. and Amherst, Mass., USA, Cairo, Egypt, Padova, Italy, and Kampala, Uganda Background: Nodding Syndrome is an idiopathic seizure disorder of children in sub-Saharan Africa. The disorder is reported to be spreading in South Sudan and northern Uganda. Objective: To describe environmental, nutritional, infectious, and other factors that existed before and during the de novo 1991 appearance and subsequent increase in cases through 2001 in then-southern Sudan. Methods: Household surveys, informant interviews, and case-control studies conducted in Lui town and Amadi village in 2001-2002 were supplemented in 2012 by informant interviews in Lui and Juba. Results: Nodding Syndrome was associated with Onchocerca volvulus and Mansonella perstans infections, with food use of a variety of sorghum (serena) introduced as part of an emergency relief program, and inversely associated with a history of measles infection. There was no evidence to suggest exposure to a manmade neurotoxic pollutant or chemical agent, other than chemically dressed seed intended for planting but used for food. Food use of cyanogenic plants was documented, and exposure to fungal contaminants could not be excluded. Conclusion: Nodding Syndrome in South Sudan has an unknown etiology. Further research is recommended on the association of Nodding Syndrome with onchocerciasis/mansonelliasis and neurotoxins in plant materials used for food.
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P1
Heart Rate Variability as a Potential Indicator of Prodromal Parkinson's Disease S.W. Cash, S.M. Goldman, S.S. Sullivan, G.S. Bhudhikanok, K. Comyns, C. Meng, L. Rees, C.M. Tanner, J.W. Langston Sunnyvale, and Palo Alto, Calif., USA Objective: Evaluate the potential utility of heart rate variability (HRV) in identifying prodromal Parkinson's disease (PD) by investigating HRV in persons with PD, idiopathic REM sleep behavior disorder (iRBD), and controls. Background: PD likely develops many years prior to the onset of motor symptoms, providing a long latent period for intervention if detected early. A large proportion of iRBD patients develop PD, and thus may be considered to have prodromal PD. Cardiac autonomic dysfunction (CAD) may be an early manifestation of PD and has been reported in iRBD. HRV derived from an EKG is a non-invasive measure of CAD, and could potentially serve as a prodromal PD indicator. Methods: PD patients (n = 12), polysomnographically verified iRBD patients (n = 4), and healthy controls (n = 9) underwent a 5-minute resting EKG. RR intervals were extracted, ectopic beats removed, and HRV measures calculated using Kubios v.2.0 software. Pairwise group differences were assessed using nonparametric Mann-Whitney U tests. Trends across all three groups were assessed using nonparametric Jonckheere-Terpstra tests with exact p-values. Results: SDHR and RRTRI (time-domain measures) were significantly lower in PD cases than controls (p = 0.009 and p = 0.034, respectively). Significant frequency-domain differences were observed for VLF(ms 2 ) (p = 0.012), LF(ms 2 ) (p = 0.003), total power(ms 2 ) (p = 0.018), LF(nu) (p = 0.028), HF(nu) (p = 0.028), and LF/HF (p = 0.028). Trends across PD, iRBD, and control groups were seen for SDHR (p = 0.006), RRTRI (p = 0.024), VLF(ms 2 ) (p = 0.015), LF(ms 2 ) (p = 0.003), total power(ms 2 ) (p = 0.011), LF(nu) (p = 0.018), HF(nu) (p = 0.018), and LF/HF (p = 0.018). Age-and gender-adjusted logistic regression models yielded similar results. Conclusions: Most HRV measures differed for PD patients compared to controls, signifying cardiac dysautonomia. Significant trends across groups were observed for several HRV measures, with iRBD patient values intermediate between controls and PD patients, consistent with the hypothesis that many iRBD patients have prodromal PD. EKG-derived HRV could prove useful in identifying prodromal PD.
